ASCO Reading Room | Modifiable determinants of mortality and secondary cancer risk in testicular cancer survivors

Testicular cancer treatments have been associated with higher non-cancer mortality and increased risk of secondary cancer in testicular cancer (TCS) survivors. For example, Hellesnes et al. previously demonstrated that TCS have an estimated 53% higher risk of secondary cancers and a 23% higher risk of non-testicular cancer deaths. This population remains at risk for chronic […]

Scroll to top